Are hemodynamic goals viable in tailoring heart failure therapy?
From Brigham and Women s Hospital Cardiovascular Division, Advanced Heart Disease Section, Boston, Mass (L.W.S.); the Heart Failure and Transplant Program, Department of Medicine, Section of Cardiology, Tulane University School of Medicine (T.H.L.J.); Cardiovascular Research, Department of Medicine, Section of Cardiology, Tulane University School of Medicine; and Department of Biomedical Engineering, Tulane University School of Engineering (E.U.A.), New Orleans, La. Correspondence to Lynne Warner Stevenson, MD, Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115; or Thierry H. Le Jemtel, MD, Tulane University School of Medicine, 1430 Tulane Ave, SL 48, New Orleans, LA 70112 (e-mail lejemtel{at}tulane.edu’ + u + ‘@’ + d + ”//–>).
